Elevated troponin level with negative outcome was found in ischemic stroke

Buse Hasırcı1, Münevver Okay, Dilek Ağırcan

  • 1Department of Neurology, Istanbul Medeniyet University Medical Faculty, 34720 Istanbul, Turkey.

Insights

Elevated cardiac troponin-I (cTnI) levels in acute ischemic stroke patients correlate with more severe neurological deficits and anterior circulation involvement. This finding suggests cTnI may indicate stroke severity.

Area of Science:

  • Neurology
  • Cardiology
  • Biomarkers

Background:

  • Troponin increment is a sensitive marker of myocardial necrosis.
  • The cause of elevated troponin in acute stroke is unclear.
  • Cardiac troponin-I (cTnI) is a specific biomarker for myocardial damage.

Purpose of the Study:

  • To investigate the relationship between cardiac troponin-I (cTnI) levels and acute ischemic stroke.
  • To determine if cTnI elevation is associated with stroke severity or specific stroke characteristics.

Main Methods:

  • Recruited 868 patients with acute ischemic stroke confirmed by diffusion MRI.
  • Excluded patients with other causes of elevated troponin.
  • Included 239 patients, assessing neurological deficits using modified Rankin Scale (mRS) and NIH Stroke Scale (NIHSS).

Main Results:

  • Serum troponin levels were higher in ischemic stroke patients with anterior circulation involvement compared to posterior or hemorrhagic stroke.
  • Higher troponin levels correlated with increased stroke scale scores at discharge in ischemic stroke patients.
  • cTnI levels correlated with stroke scale scores at admission and discharge in posterior stroke patients.

Conclusions:

  • Elevated cTnI is associated with more severe neurological deficits in acute ischemic stroke.
  • cTnI elevation may serve as an indicator of stroke severity and extent.
  • Further research is needed to elucidate the exact mechanisms linking cTnI to stroke outcomes.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.